| Trial ID: | L0458 |
| Source ID: | IRCT20190602043787N1
|
| Associated Drug: |
Silymarin
|
| Title: |
Triple-blind clinical trial on the effect of a combination of garlic, silymarin and curcumin in comparison with placebo in the treatment of non-alcoholic fatty liver disease
|
| Acronym: |
--
|
| Status: |
Recruiting
|
| Study Results: |
No Results Available
|
| Results: |
--
|
| Conditions: |
fatty liver disease. <br>Fatty (change of) liver, not elsewhere classified;K76.0
|
| Interventions: |
Intervention 1: Intervention group:The intervention group received routine treatment with low intake of carbohydrate and fat with the administration of curcumin. garlic, silymarin in Soft gel , will be gave to patients for three months.curcumin has gave
|
| Outcome Measures: |
1.decrease in serum level of ALT. Timepoint: at the baseline and 3 months after intervention. Method of measurement: autoanalyzer bt3000.Decrease in ultrasonographic grading. Timepoint: at the baseline and 3 months after intervention. Method of measurement: ultrasonography.
|
| Sponsor/Collaborators: |
Mashhad University of Medical Sciences
|
| Gender: |
All
|
| Age: |
18 years70 years
|
| Phases: |
Phase 2/Phase 3
|
| Enrollment: |
60
|
| Study Type: |
interventional
|
| Study Designs: |
Randomization: Randomized, Blinding: Triple blinded, Placebo: Used, Assignment: Parallel, Purpose: Treatment, Randomization description: Patients were devided to two groups by simple randomization through random number table that produced from PASS softw
|
| Start Date: |
09/08/2019
|
| Completion Date: |
--
|
| Results First Posted: |
--
|
| Last Update Posted: |
7 October 2019
|
| Locations: |
Iran (Islamic Republic of)
|
| URL: |
http://en.irct.ir/trial/40018
|
